Chris Collins: “It was let's launch it on October 1 because we promised it would be October 1 whether it is ready, whether it is secure…”

I have a sign in my office, 'In God we trust, all others bring data.'

putting any type of delay into this sphere of personalized medicine and treatment especially in the cancer and oncology world runs the risk frankly of causing people to die

We either invest to accelerate or we are going to lose ground.

It is about respecting the taxpayers. That is why this hearing is occurring.